These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19527762)

  • 1. Using real data for a virtual crossmatch.
    Zachary AA; Sholander JT; Houp JA; Leffell MS
    Hum Immunol; 2009 Aug; 70(8):574-9. PubMed ID: 19527762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.
    Ellis TM; Schiller JJ; Roza AM; Cronin DC; Shames BD; Johnson CP
    Hum Immunol; 2012 Jul; 73(7):706-10. PubMed ID: 22537747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant.
    Claas FH; Doxiadis II
    Hum Immunol; 2009 Aug; 70(8):636-9. PubMed ID: 19375467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which human leukocyte antigen antibodies are really clinically relevant?
    Opelz G; Claas FH
    Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS; Bennett G; Bardy P; Coghlan P; Russ GR; Coates PT
    Hum Immunol; 2009 Aug; 70(8):595-9. PubMed ID: 19527759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation.
    Taylor CJ; Kosmoliaptsis V; Summers DM; Bradley JA
    Hum Immunol; 2009 Aug; 70(8):563-8. PubMed ID: 19445992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
    Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
    Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified solid-phase alloantibody detection for improved crossmatch prediction.
    Wahrmann M; Hlavin G; Fischer G; Marinova L; Schwaiger E; Hörl WH; Zlabinger GJ; Körmöczi GF; König F; Böhmig GA
    Hum Immunol; 2013 Jan; 74(1):32-40. PubMed ID: 23073293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
    Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
    Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
    Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC
    Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
    Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.